You are not logged in.
Please login to continue selecting trials.
Generic NameTrabectedinProduct NameYONDELIS®Therapeutic AreaCancers and Other NeoplasmsEnrollment121% Female38.8%% White88.4%
Product ClassAntineoplastic AgentsSponsor Protocol NumberET-C-002-07Data PartnerJohnson & JohnsonCondition StudiedSarcomaMean/Median Age (Years)48
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Please note: individual participant-level data are not available for this trial. Only the protocol, statistical analysis plan, and full clinical study report are available.